Metabolic HealthTirzepatide Achieves 16% Weight Loss in 24 Weeks When Paired With Diet and Exercise
A 24-week real-world study of 122 adults with overweight or obesity found that tirzepatide — combined with a low-carbohydrate diet and tailored exercise — produced dramatic improvements in body weight and composition. Participants lost an average of 15 kg, reduced fat mass by 35%, and preserved skeletal muscle mass. BMI dropped from 35 to 29, and waist circumference fell by 17 cm. Critically, insulin resistance (HOMA-IR) improved significantly, and the reduction in fat mass correlated directly with insulin improvement. Strikingly, the 16% weight loss achieved in just 24 weeks matched what the pivotal SURMOUNT-1 clinical trial reported after 72 weeks, suggesting that integrating structured lifestyle interventions with tirzepatide in real-world clinical practice may substantially accelerate and amplify outcomes beyond what trials alone predict.
